4Ngarapasutadol J, Ram S, Blom AM, et al. Human C4b-binding protein selectively interacts with Neisseria gonorrhoeae and results in species-specific infection. Proe Nail Acad Sci U S A, 2005, 102(47) : 17142-17147.
5Perez-Losada M, Viscidi RP, Demma JC, et al. Population genetics of Neisseria gonorrhoeae in a high-prevalence community using a hypervariable outer membrane porB and 13 slowly evolving housekeeping genes. Mol Biol Evol, 2005, 22 (9) : 18871902.
6Simpson SD, Ho Y, Rice PA, et al. T lymphocyte response to Neisseria gonorrhoeae porin in individuals with mucosal gonococcal infections. J Infect Dis, 1999, 180(3) : 762-773.
7Wetzler LM, Blake MS, Gotschlich EC. Characterization and specificity of antibodies to protein I of Neisseria gonorrhoeae produced by injection with various protein I-adjuvant preparations. J Exp Med, 1988, 168 (5): 1883-1897.
8Clark RA, Thcall KP, Kissinger P. Consideration for Empiric Trichomonas vaginalis treatment among sleectled high-risk HIV - infect female populations with concurrent Neisseria gonorrhea or Chlamydia trachomatis cervical infections[J]. Sex Transm Dis,2006,33(2): 124-125.
9Bolan GA, Sparling PF, Wasserheit IN. The emerging threat of untreatable gonococcal infection [J]. N Engl J Med,2012,366(6):485-487.
10Golden MR, Whittington WL, Handsfield HH. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. [J]. N Engl J Med,2005,352(7):676-685.
